Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.92 is 71% below its 5-year average of 6.69, near the low end of its 5-year range (1.73–12.79).
As of the fiscal period ended Tuesday, June 30, 2026. 8.24% below its 12-month average of 2.10.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.92.
CURRENT RATIO
1.92
CURRENT RATIO AVG TTM
2.10
CURRENT RATIO AVG 3Y
5.38
CURRENT RATIO AVG 5Y
6.69
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.24%
CURRENT VS 3Y AVG
-64.25%
CURRENT VS 5Y AVG
-71.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-48.69%
vs the sector median at left
Phathom Pharmaceuticals, Inc.
Market Cap
$548.51M
Current Ratio
1.92
TTM Avg
2.10
3Y Avg
5.38
5Y Avg
6.69
Market Cap
$557.32M
Current Ratio
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
Market Cap
$533.04M
Current Ratio
33.56
TTM Avg
31.41
3Y Avg
17.80
5Y Avg
16.41
Market Cap
$529.58M
Current Ratio
27.59
TTM Avg
10.29
3Y Avg
10.12
5Y Avg
12.12
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | $548.51M | 1.92 | 2.10 | 5.38 | 6.69 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $557.32M | 9.36 | 2.17 | 1.76 | 2.63 |
| ProKidney Corp. (PROK)vs › | $538.01M | 8.36 | 10.03 | 20.35 | 14.11 |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| Monopar Therapeutics Inc. (MNPR)vs › | $533.04M | 33.56 | 31.41 | 17.80 | 16.41 |
| Delcath Systems, Inc. (DCTH)vs › | $531.98M | 9.83 | 11.46 | 6.57 | 5.79 |
| Nuvectis Pharma, Inc. (NVCT)vs › | $531.52M | 1.68 | 2.23 | 2.63 | 2.59 |
| Shattuck Labs, Inc. (STTK)vs › | $529.58M | 27.59 | 10.29 | 10.12 | 12.12 |
| CorMedix Inc. (CRMD)vs › | $571.13M | 2.56 | 2.75 | 5.48 | 7.66 |
| Immix Biopharma, Inc. (IMMX)vs › | $524.43M | 25.13 | 6.17 | 7.34 | 19.91 |
Current Ratio
1.92
Quick Ratio
1.87
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.92 |
| 2026-03-31 | 2.21 |
| 2025-12-31 | 1.73 |
| 2025-09-30 | 2.23 |
| 2025-06-30 | 2.38 |
| 2025-03-31 | 3.58 |
| 2024-12-31 | 4.20 |
| 2024-09-30 | 5.73 |
| 2024-06-30 | 6.48 |
| 2024-03-31 | 7.83 |
| 2023-12-31 | 10.25 |
| 2023-09-30 | 9.46 |
| 2023-06-30 | 11.96 |
| 2023-03-31 | 9.68 |
| 2022-12-31 | 6.12 |
| 2022-09-30 | 8.60 |
| 2022-06-30 | 9.93 |
| 2022-03-31 | 12.79 |
| 2021-12-31 | 9.86 |
| 2021-09-30 | 8.10 |
| 2021-06-30 | 5.34 |
| 2021-03-31 | 5.94 |
| 2020-12-31 | 5.25 |
| 2020-09-30 | 8.21 |
| 2020-06-30 | 18.76 |
| 2020-03-31 | 57.22 |
| 2019-12-31 | 68.20 |
| 2019-09-30 | 0.37 |
| 2019-06-30 | 0.58 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 0.41 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
